Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Magalhaes

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 25, 2010
An accurate and interpretable model for BCCT.coreHelder P Oliveira, Andre Magalhaes, Maria J Cardoso, et al.
Hematology, Transfusion and Cell Therapy|September 17, 2023
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality -cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)Marcia Garnica, Edvan De Queiroz Crusoe, Glaciano Ribeiro, et al.
Hematology, Transfusion and Cell Therapy|September 21, 2019
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantationEdvan De Queiroz Crusoe, Fabiana Higashi, Gracia Martinez, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 25, 2010
An accurate and interpretable model for BCCT.coreHelder P Oliveira, Andre Magalhaes, Maria J Cardoso, et al.
Hematology, Transfusion and Cell Therapy|September 17, 2023
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality -cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)Marcia Garnica, Edvan De Queiroz Crusoe, Glaciano Ribeiro, et al.
Hematology, Transfusion and Cell Therapy|September 21, 2019
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantationEdvan De Queiroz Crusoe, Fabiana Higashi, Gracia Martinez, et al.
Pageof 1